FIELD: medicine, laboratory diagnostics.
SUBSTANCE: at detecting tumoral ovarian neoplasm, at the stage of preoperational procedure one should additionally detect the concentration of alpha-2-glycoprotein (ABG) in blood serum due to rocket immunoelectrophoresis, and at its concentration being 0.008-0.019 g/l one should diagnose benign ovarian tumoral process and match laparoscopic access in case of operative interference; at concentration of 0.024 g/l and more one should diagnose high risk for availability of malignant tumoral process and match laparotomy as an access for operative interference. Thus, the innovation provides the reason for matching the access for operative interference that enables to decrease the frequency of traumatic interference and risk of postoperational complications.
EFFECT: higher efficiency.
4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINATION OF ORIENTATION OF PATHOLOGICAL PROCESS AT CANCER OF OVARIES | 2007 |
|
RU2350966C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING TUMOR PROCESSES IN OVARIES | 2006 |
|
RU2313794C1 |
| LAPAROSCOPY METHOD FOR TREATING PATIENTS FOR MALIGNANT OVARY TUMORS AFTER NON-RADICAL OPERATION | 2003 |
|
RU2251987C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NEOPLASMS OF OVARIES | 2018 |
|
RU2686180C1 |
| METHOD OF SELECTION OF PELVIC EXENTERATION TACTICS | 2023 |
|
RU2808914C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING BENIGN AND MALIGNANT NEOPLASMS IN INTERNAL FEMALE SEXUAL ORGANS | 2006 |
|
RU2323439C1 |
| METHOD OF EARLY DIAGNOSTICS OF OVARY TUMOURS | 2007 |
|
RU2334986C1 |
| METHOD FOR PREDICTING MALIGNANT NEOPLASMS IN SMALL PELVIC ORGANS | 2004 |
|
RU2246259C1 |
| METHOD FOR DYNAMIC MAGNETIC RESONANCE DIAGNOSIS OF MALIGNANT TUMOURS OF OVARIES | 2015 |
|
RU2578184C1 |
| METHOD FOR CARRYING OUT ULTRASONIC DIAGNOSTIC EXAMINATION FOR DETERMINING INDIVIDUAL RESIDUAL OVARIAN TUMOR SENSITIVITY TO CHEMOTHERAPY | 2002 |
|
RU2239362C2 |
